Order results by:
| Issue | Title | |
| Vol 17, No 4 (2024) | Dynamics of anticancer drug use in Russian hospitals: a five-year retrospective analysis | Abstract similar documents |
| J. A. Agafonova, V. V. Omelyanovskiy | ||
| "... issues, particularly the use of oral anticancer drugs (ACDs) in day hospitals. These facilities often ..." | ||
| Vol 12, No 4 (2019) | Optimization of drug supply for patients with malignant neoplasms in a region of the Russian Federation | Abstract similar documents |
| A. V. Nikitina, F. V. Gorkavenko, Y. S. Saybel, M. V. Avxentyeva, M. S. Sura, D. V. Fedyaev | ||
| "... The aim was to assess the possibility of optimizing the costs of drugs for cancer patients ..." | ||
| Vol 11, No 3 (2018) | What is the role of antineoplastic drug safety in reimbursement decision making? | Abstract similar documents |
| A. S. Kolbin, A. A. Kurylev | ||
| "... Rationale. From 2014 to 2017, the portion of antineoplastic drugs dossiers submitted ..." | ||
| Vol 18, No 1 (2025) | The sale of medicines used for diabetes mellitus treatment in retail segment of Russian pharmaceutical market | Abstract similar documents |
| I. K. Petrukhina, A. M. Lazarev, T. K. Ryazanova, P. A. Lebedev, E. P. Gladunova, G. T. Glembotskaya | ||
| "... for drugs used to treat DM (according to Anatomical Therapeutic Chemical (ATС) classification) through ..." | ||
| Vol 18, No 2 (2025) | Population consumption of antihypertensive and lipid-lowering drugs in the Russian Federation (SPARDEC) | Abstract similar documents |
| Zh. D. Kobalava, I. K. Petrukhina, P. A. Lebedev, P. R. Blinkova, T. K. Ryazanova, E. P. Gladunova, E. V. Paranina | ||
| "... the need for long-term pharmacotherapy with antihypertensive and lipid-lowering drugs. Objective: To study ..." | ||
| Vol 12, No 4 (2019) | Clinical and economic analysis of drug costs in a general hospital in 2014-2018 | Abstract similar documents |
| A. T. Burbello, A. S. Fedorenko, E. L. Latariya, M. V. Pokladova, K. A. Zagorodnikova | ||
| "... Objectives. To study the structure of drug purchases by a general hospital considering the names ..." | ||
| Vol 9, No 1 (2016) | MATHEMATICAL MODEL OF REIMBURSEMENT DECISION MAKING IN RUSSIA. RESULTS OF VIM LIST FOR 2016 | Abstract similar documents |
| A. S. Kolbin, A. V. Prasolov, E. A. Maksimkina, Yu. E. Balykina, Z. M. Golant, Yu. S. Polushin, A. A. Kurylev, I. A. Vilyum | ||
| "... Background: In 2014 we firstly analyzed the formalized system (points and expert opinions) of drug ..." | ||
| Vol 15, No 1 (2022) | The analysis of the consumption level of antihypertensive drugs and statins in a retail pharmacy of the Samara Region in 2015–2020 | Abstract similar documents |
| I. K. Petrukhina, P. A. Lebedev, E. P. Gladunova, T. K. Ryazanova, A. A. Garanin, P. R. Blinkova | ||
| "... Objective: to determine the compliance of antihypertensive drugs consumption with the trends ..." | ||
| Vol 17, No 1 (2024) | Analysis of the availability of bronchodilators and anti-inflammatory drugs for patients with chronic obstructive pulmonary disease | Abstract PDF (Eng) similar documents |
| E. A. Orlova, V. I. Petrov, I. P. Dorfman, O. V. Shatalova, M. A. Orlov | ||
| "... Background. The study of drug availability for patients with chronic obstructive pulmonary disease ..." | ||
| Vol 12, No 2 (2019) | Dynamics of prices and consumption of anticancer drugs in Russia after their generics and biosimilars became available | Abstract similar documents |
| F. V. Gorkavenko, A. V. Nikitina, E. S. Saibel’, M. V. Avksent’eva, M. V. Sura, D. V. Fedyaev | ||
| "... trends in the general picture of drug prices and consumption. In the present study, we analyze ..." | ||
| Vol 17, No 3 (2024) | Assessment of the impact of procurement centralization on the drug provision for patients within the High-Cost Nosology Program in the Russian Federation | Abstract similar documents |
| V. V. Omelyanovskiy, V. A. Ryagina, A. G. Kharitonova, K. I. Matrenin, A. A. Kingshott, O. V. Ashikhmina, M. V. Zhirov | ||
| "... Background. In the Russian Federation, patients receive expensive drugs from the federal budget ..." | ||
| Vol 17, No 3 (2024) | Differential chemoproteomic analysis of RRS-1 candidate molecule and molecules of several nonsteroidal anti-inflammatory drugs | Abstract similar documents |
| P. A. Galenko-Yaroshevsky, I. Yu. Torshin, A. N. Gromov, O. A. Gromova, K. F. Suzdalev, R. A. Murashko, A. V. Zelenskaya, A. V. Zadorozhniy, T. R. Glechyan, G. V. Simavonyan, E.M. I. Muhammad | ||
| "... to evaluate the mechanisms and spectrum of action of nonsteroidal anti-inflammatory drugs (NSAIDs), including ..." | ||
| Vol 12, No 3 (2019) | Clinical and economic analysis as an instrument for harmonizing import substitution in the preferential segment of medicinal support | Abstract similar documents |
| E. V. Eliseeva , E. S. Maneeva , R. K. Goncharova , A. V. Kropotov | ||
| "... the qualitative and quantitative indicators of drug supply. Materials and methods. We used the official ..." | ||
| Vol 15, No 3 (2022) | Drug therapy for obesity in the Russian Federation: pharmacoepidemiological study | Abstract similar documents |
| V. V. Strizheletsky, Yu. М. Gomon, Е. А. Spichakova, А. S. Kolbin, А. А. Kalyapin, S. А. Makarov, А. B. Lomiya, F. М. Sultanova | ||
| "... Federation as drugs recommended by the Russian clinical guidelines for the pharmacotherapy of obesity ..." | ||
| Vol 16, No 4 (2023) | Sales of antitumor drugs in the retail segment of the Russian pharmaceutical market | Abstract similar documents |
| I. K. Petrukhina, T. K. Ryazanova, E. P. Gladunova, A. M. Lazarev, A. A. Krivova | ||
| "... Objective: to study the features of the population consumption of antitumor drugs (ATDs) of groups ..." | ||
| Vol 9, No 3 (2016) | DRUGS PROVIDED TO BREAST CANCER PATIENTS WITHIN THE STATE PROGRAMS OF DRUG SUPPLY | Abstract similar documents |
| M. V. Avxentyeva, V. I. Bogin, E. V. Derkach, V. V. Omelyanovskiy, M. B. Stenina, A. V. Tarakanov, M. Yu. Frolov | ||
| "... cancer in various regions of the Russian Federation in the framework of state programs of drug provision ..." | ||
| Vol 10, No 3 (2017) | The strategies of drug supply for patients with chronic hepatitis C | Abstract similar documents |
| E. V. Kornilova, A. D. Ermolaeva, M. G. Rusanova, D. A. Andreev, M. V. Davydovskaya, T. N. Ermolaeva, A. g Pokatilo, K. I. Polyakova, V. A. Dubovtseva, K. А. Kokushkin, A. V. Devyatkin | ||
| "... The report reviews the options of drug supply for patients with chronic hepatitis C in the Russian ..." | ||
| Vol 15, No 3 (2022) | Economic aspects of using new chemotherapy regimens for multidrug and extensively drugresistant tuberculosis | Abstract similar documents |
| А. V. Kukurika | ||
| "... drug-resistant tuberculosis (MDR/XDR-TB) chemotherapy regimens. Material and methods. An analysis ..." | ||
| Vol 9, No 2 (2016) | MANAGEMENT ASPECT OF THE PROBLEM OF NARCOTIC DRUGS USE | Abstract similar documents |
| S. Yu. Soboleva, A. V. Sobolev, I. A. Kaminskaya | ||
| "... The use of narcotic drugs in healthcare system nowadays is characterized by lawful aspects ..." | ||
| Vol 17, No 4 (2024) | Scenario modeling of the drug prescription process for children: application of machine learning methods | Abstract similar documents |
| А. А. Kondrashov, М. М. Kurashov, Е. Е. Loskutova | ||
| "... Objective: determining the most appropriate machine learning method to solve the problem of drug ..." | ||
| Vol 14, No 3 (2021) | Peculiarities of administration of medications to patients with circulatory system diseases within the framework of the federal program of preferential provision of medicines | Abstract similar documents |
| I. K. Petrukhina, R. I. Yagudina, N. V. Veyner, T. K. Ryazanova, E. P. Gladunova, V. A. Kurkin, P. R. Blinkova, E. N. Zaitseva | ||
| "... контент-анализа, метод группировки данных в соответствии с принадлежностью к группам по ..." | ||
| Online First | Osteoarthritis therapy misconcepts | Abstract similar documents |
| O. A. Shavlovskaya, О. А. Gromova, I. Yu. Torshin, I. D. Romanov | ||
| "... , as new molecules appear, data concerning drugs/molecules that are already in use, appear as well ..." | ||
| Vol 16, No 2 (2023) | From misconceptions to reasonable osteoarthritis patients therapy | Abstract similar documents |
| O. A. Shavlovskaya, О. А. Gromova, I. Yu. Torshin, I. D. Romanov | ||
| "... revised, as new molecules appear, data on drugs/molecules already in use, including data on adverse events ..." | ||
| Vol 14, No 2 (2021) | Pharmacoepidemiology and pharmacoeconomics of multidrug- and extensively drug-resistant tuberculosis | Abstract similar documents |
| N. Yu. Nikolenko, D. А. Kudlay, N. P. Doktorova | ||
| "... Treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB ..." | ||
| Vol 16, No 1 (2023) | Compounding pharmacy regulations: experience of the North American pharmaceutical market | Abstract similar documents |
| D. D. Mamedov, D. S. Yurochkin, A. A. Leshkevich, S. E. Erdni-Garyaev, Z. M. Golant, I. A. Narkevich | ||
| "... requirements for ensuring quality and safety of compounding drugs, as well as historical and technical analysis ..." | ||
| Vol 17, No 4 (2024) | Pharmacoeconomic study of active psoriatic arthritis treatment | Abstract similar documents |
| A. V. Rudakova, Т. V. Korotaeva | ||
| "... biological (b) and targeted synthetic (ts) disease-modifying antirheumatic drugs (DMARDs), available ..." | ||
| Vol 18, No 1 (2025) | Analysis of methotrexate use practice in patients with rheumatoid and psoriatic arthritis | Abstract similar documents |
| S. A. Doktorova, Yu. Yu. Grabovetskaya, A. V. Zuev, J. N. Aksenova-Sorokhtei, V. V. Rafalskiy | ||
| "... antirheumatic drugs. The current therapeutic concept for these conditions focuses on achieving and maintaining ..." | ||
| Vol 13, No 2 (2020) | Improvements to the formation of lists of drugs for medical use: analysis of changes in the Government Decree no. 871 | Abstract similar documents |
| V. V. Omelyanovskiy, E. A. Maksimkina, O. I. Ivakhnenko, M. V. Avxentyeva, M. V. Sura, G. R. Khachatryan | ||
| "... development of approaches for complex drug assessment in Russia, also criteria for its evaluation were under ..." | ||
| Online First | Differential chemoproteomic analysis of RRS-1 candidate molecule and molecules of several nonsteroidal anti-inflammatory drugs | Abstract similar documents |
| P. A. Galenko-Yaroshevsky, I. Yu. Torshin, A. N. Gromov, O. A. Gromova, K. F. Suzdalev, R. A. Murashko, A. V. Zelenskaya, A. V. Zadorozhniy, T. R. Glechyan, G. V. Simavonyan, E. M.I. Muhammad | ||
| "... to evaluate the mechanisms and spectrum of action of nonsteroidal anti-inflammatory drugs (NSAIDs), including ..." | ||
| Vol 9, No 1 (2016) | PHARMACOECONOMIC EVALUATION OF RUFINAMIDE USE FOR THE LENNOX-GASTAUT SYNDROME TREATMENT | Abstract similar documents |
| N. K. Mazina, P. V. Mazin, Yu. V. Kislitsin, E. M. Markova | ||
| "... to evaluate the efficacy of the drug in this pathology, a systematic review of publications of the results ..." | ||
| Vol 11, No 1 (2018) | Modeling microbial drug-resistance: from mathematics to pharmacoeconomics | Abstract similar documents |
| Yu. M. Gomon, M. A. Arepyeva, Yu. E. Balykina, A. S. Kolbin, A. A. Kurylev, M. A. Proskurin, S. V. Sidorenko | ||
| "... optimal algorithm for using antimicrobial agents (AMA) that would minimize the evolving drug-resistance ..." | ||
| Vol 9, No 2 (2016) | PHARMACOECONOMIC ANALYSIS OF VESOMNI (SOLIFENACIN AND CONTROLLED RELEASE TAMSULOSIN) TREATMENT OF STORAGE SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA | Abstract similar documents |
| N. A. Avxentyev, M. Yu. Frolov | ||
| "... The aim of the current study is pharmacoeconomic evaluation of using combined drug Vesomni ..." | ||
| Vol 9, No 3 (2016) | CLINICAL AND ECONOMIC EVALUATION OF LACOSAMIDE IN PATIENTS WITH PARTIAL EPILEPSY | Abstract similar documents |
| E. A. Pyadushkina, M. Yu. Frolov | ||
| "... of the Russian Federation in three scenarios: Lacosamide as concomitant drug to standard therapy in comparison ..." | ||
| Vol 18, No 2 (2025) | Pharmacoeconomic study of oral anticancer therapy: results of combined ABC/VEN and frequency analysis | Abstract similar documents |
| J. A. Agafonova | ||
| "... is especially valuable when analyzing contemporary oral anticancer drugs, which are playing an increasingly ..." | ||
| Vol 9, No 2 (2016) | METASTATIC COLORECTAL TREATMENT COSTS OF USING TARGETED DRUGS IN SECOND AND FURTHER LINES THERAPY | Abstract similar documents |
| N. A. Avxentyev, E. V. Derkach, E. A. Pyadushkina, M. D. Ter-Ovanesov | ||
| "... Targeted drugs are recommended for treatment of metastatic colorectal cancer. Second and further ..." | ||
| Vol 15, No 3 (2022) | Prospects for the use of chondroitin sulfate and glucosamine sulfate in the treatment of patients with obesity-associated osteoarthritis (metabolic syndrome) | Abstract similar documents |
| I. Yu. Torshin, О. A. Gromova, A. M. Lila | ||
| "... хондроитина сульфатов (ХС) приводят к хронизации воспаления и развитию комплекса коморобидных патологий ..." | ||
| Vol 16, No 4 (2023) | DMOADs and DMARDs in the treatment of patients with joint and spine diseases | Abstract PDF (Eng) similar documents |
| O. A. Shavlovskaya | ||
| "... The data on the classification of drugs, which are prescribed for the treatment of patients ..." | ||
| Vol 11, No 4 (2018) | Treatment of patients with malignant lymphoproliferative diseases in the Russian Federation: analysis of the data from 75 regions | Abstract similar documents |
| G. R. Hachatryan, T. S. Teptsova, V. A. Lemeshko, N. Z. Musina | ||
| "... . Among the malignant LPDs, the highest costs of drug therapy in 2016 pertained to lymphosarcoma ..." | ||
| Vol 14, No 2 (2021) | Medical care payment improvement within diagnosis-related groups of patients with severe asthma requiring biologic disease-modifying drugs by regional adaptation mechanism in the Moscow Region | Abstract similar documents |
| A. D. Ermolaeva, V. S. Krysanova, T. N. Ermolaeva, K. I. Polyakova, K. A. Kokushkin | ||
| "... drugs (bDMDs) within the constraints of diagnosis-related groups (DRGs) on the level of the Moscow ..." | ||
| Vol 14, No 4 (2021) | Features of intellectual property protection mechanisms on the example of orphan drugs circulation | Abstract similar documents |
| D. S. Yurochkin, К. V. Nasonova, Z. М. Golant, I. А. Narkevich, V. P. Trukhin | ||
| "... of drugs for the treatment of rare (orphan) diseases. Material and methods. Analysis of pharmaceutical ..." | ||
| Vol 15, No 4 (2022) | Analysis of the main indicative values of the pharmaceutical market retail sectors in the constituent entities of the Russian Federation | Abstract similar documents |
| I. К. Petrukhina, Т. К. Ryazanova, А. I. Khusainova, А. V. Egorova, P. R. Blinkova | ||
| "... of dosage forms, sales of drugs, psychotropic substances and their precursors included in the Lists II ..." | ||
| Vol 14, No 2 (2021) | Analysis of the availability and affordability of pharmaceuticals for children in need of palliative care | Abstract similar documents |
| D. M. Medvedeva, I. A. Narkevich, O. D. Nemyatykh | ||
| "... high scores of over-the-counter drugs (LDI>60%). Conclusions. The results call for better ..." | ||
| Vol 16, No 4 (2023) | Investigating the current state of the Russian market for drugs treating infectious and inflammatory conditions of oral cavity and oropharynx to demonstrate the need for new drug development | Abstract PDF (Eng) similar documents |
| V. I. Zvereva, D. R. Dzhavakhyan, V. N. Dul, V. S. Bobyleva, A. A. Markaryan, E. I. Morkovin, D. V. Kurkin, M. A. Dzhavakhyan | ||
| "... Objective: to assess the relevance and commercial prospects of bringing to market a drug ..." | ||
| Vol 16, No 2 (2023) | Development of methodological approaches to the formation of a risk-based model to minimize the prevalence of adverse reactions in drug application in medical organizations of Moscow | Abstract similar documents |
| E. V. Kuznetsova, M. V. Zhuravleva, I. A. Mikhailov, T. I. Kurnosova | ||
| "... using drugs based on a comprehensive assessment of risk factors. Material and methods. We used ..." | ||
| Vol 14, No 2 (2021) | Organizational and economic aspects of triplet therapy of relapsed/refractory multiple myeloma in the Russian healthcare setting | Abstract similar documents |
| E. A. Pyadushkina, E. V. Derkach, V. I. Ignatyeva, E. E. Yagnenkova, T. Yu. Klitochenko, T. V. Shelekhova, A. N. Levanov | ||
| "... Background. The introduction of innovative drugs has significantly increased the treatment ..." | ||
| Vol 17, No 1 (2024) | Compounding pharmacy regulations: experience of the Latvian pharmaceutical market | Abstract similar documents |
| D. D. Mamedov, D. S. Yurochkin, D. D. Zelikova, S. E. Erdni-Garyaev, Z. M. Golant, I. A. Narkevich | ||
| "... The article aims to examine technological, organizational and regulatory aspects of drug quality ..." | ||
| Vol 14, No 1 (2021) | Development of a method for the analysis of the lists of medicines and its application for the analysis of the lists of medicines in Russia, England, and Italy | Abstract similar documents |
| V. A. Lemeshko, K. I. Matrenin, V. V. Omelyanovskiy, Yu. V. Vasilyeva, G. R. Khachatryan, L. A. Kolganov | ||
| "... and Italy exceeds the total number of drugs included in the list of vital essential and desirable (VED ..." | ||
| Vol 16, No 2 (2023) | Key principles of drug therapy in patients with chronic myeloid leukemia | Abstract similar documents |
| A. V. Zhuravlev, O. I. Knysh | ||
| "... Objective: to summarize scientific information about the basic principles of modern drug therapy ..." | ||
| Vol 11, No 2 (2018) | Pharmacoeconomic analysis of treatment with nilotinib as the second line therapy in patients with chronic myeloid leukemia | Abstract similar documents |
| N. A. Avxentyev, M. Yu. Frolov, A. S. Makarov | ||
| "... are registered in second-line, however only dasatinib is included in the government drug reimbursement program ..." | ||
| Vol 17, No 1 (2024) | Pharmacoeconomic evaluation of first-line combination therapy with immunotherapy drugs and platinum-containing chemotherapy in adult patients with metastatic non-squamous non-small cell lung cancer | Abstract similar documents |
| S. К. Zyryanov, I. N. Dyakov | ||
| "... + carboplatin” drug combination compared to “pembrolizumab + pemetrexed + carboplatin” combination in adult ..." | ||
| 1 - 50 of 75 Items | 1 2 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
